Central nervous system (CNS) disorders and diseases are expected to rise sharply in the
coming years, partly because of the world's aging population. Medicines for the treatment of …

Neurological disorders are ranked as a leading disorder under the subgroup of disability-
adjusted life years (DALYs) in 2015 under the global burden of diseases and second …

Alzheimer's disease (AD) is clinically characterized as memory deficits, altered behavior and
impaired cognitive functions. The most important risk factor for AD is aging and mounting …

Neurodegenerative disorders, which are defined by the breakdown of neurons over time,
are affecting an increasing number of people. Stroke, Alzheimer's, Parkinson's, Multiple …

Neurodegenerative disorders (NDDs) are multifaceted complex disorders that have put a
great health and economic burden around the globe nowadays. The multi-factorial nature of …

Alzheimer's disease (AD) and dementia are disorders of the aging population and becoming
major health care burden worldwide due to unavailability of complete therapy. AD is the …

Aging is described as an advanced time-related collection of changes that may negatively
affect with the risk of several diseases or death. Aging is a main factor of several age-related …

Alzheimer's disease (AD) and Parkinson's disease (PD) are two most common
neurodegenerative diseases that primarily target the elderly population in society. The …

Neurodegenerative diseases are caused by the gradual loss of neurons' function. These
neurological illnesses remain incurable, and current medicines only alleviate the symptoms …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder and is the most common
cause of progressive dementia in aging. Research on AD therapy has been partly …